nVerses Capital’s Organon & Co OGN Stock Holding History

nVerses Capital’s Portfolio OGN Stock Details OGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-13,600	Closed	-$260K	–	603
2024 Q3	$260K	Buy	+13,600	New	+$282K	0.12%	269

Other funds holding OGN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Pacer Advisors Malvern, Pennsylvania $39.3B AUM 27.96% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return

SSM

Sound Shore Management Greenwich, Connecticut $3.25B AUM 28.47% 1-Year Est. Return

DRZID

DePrince Race & Zollo Inc (DRZ) Winter Park, Florida $5.96B AUM 38.5% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

nVerses Capital's OGN Position: Q4 2024 in Review

nVerses Capital sold out of Organon & Co (OGN) in Q4 2024, closing a stake of 13,600 shares — an estimated $260K sold.

nVerses Capital first reported a position in OGN in Q3 2024 and held it in 1 quarter. The position peaked at $260K in Q3 2024. 740 funds tracked by Wall St. Rank hold OGN as of Q4 2024.

nVerses Capital reported no remaining Organon & Co position as of Q4 2024 after selling out during the quarter.
nVerses Capital sold 13,600 Organon & Co shares in Q4 2024, an estimated $260K.
nVerses Capital first reported a position in Organon & Co in Q3 2024 and held it in 1 quarter.
nVerses Capital's Organon & Co position peaked at $260K in Q3 2024.
740 funds tracked by Wall St. Rank held Organon & Co as of Q4 2024.

Based on nVerses Capital's 13F filing for Q4 2024.